Search Results: obesity (214)

Nearly 100,000 Malaysians Faced Premature Death Due to NCDs in 2022

By 0

In a concerning statistic emerging from Malaysia, almost 100,000 individuals succumbed prematurely to various non-communicable diseases (NCDs) in 2022, falling short of the national average life expectancy of 75 years.  The primary culprits behind these early deaths were heart and cerebrovascular diseases, along with pneumonia, underscoring a pressing health crisis in the country.

What are the Differences Between Type 1 and Type 2 Diabetes?

By 0

Dr Goh shared that “The complications from both type 1 and type 2 diabetes have serious complications when they attack blood vessels. When this happens, it can cause microvascular heart diseases and lead to blindness, kidney failure, loss of sensations in the nerve and more. Macrovascular heart disease causes heart attack and stroke.

Type 1 diabetes usually has more complications and has a greater impact on reducing the lifespan. However, in both diseases, the life expectancy is reduced. Therefore, the patient is better off getting a reversal cure via metabolic surgery. 

Not just weight loss – Semaglutide and Cardiovascular Benefits

By 0
With the emergence and increasing popularity of glucagon-like peptide 1 (GLP-1) agonists for the treatment of obesity in recent years, it might be worth investigating if these agents are able to reduce the cardiovascular risks associated with overweight and obesity, especially since they have been shown to reduce risk of major adverse cardiovascular events in patients with type 2 diabetes who are at high cardiovascular risk.

Log In or Register as a healthcare professional to read the full article.